Terlipressin 0.1 mg/ml Injection Ampoule
Eustoma Laboratories Pvt. Ltd. · Verified Seller · Bhopal, Madhya Pradesh
Terlipressin 0.1 mg/ml Injection Ampoule: supplied from Bhopal, Madhya Pradesh by Eustoma Laboratories Pvt. Ltd. Verified seller on Tradoi. At ₹300/piece, MOQ 10 units.
Price and Order
| Price | ₹300 per piece |
|---|---|
| Minimum Order Quantity | 10 units |
- Tracked Order
- Private Contact
- Tradoi-Verified Seller
Specifications
From the Seller's Listing
| Category | Healthcare & Medical › Pharmaceutical Products › Injectables & Infusions |
|---|---|
| Unit | piece |
| Api Name | Terlipressin |
| Excipients | Water for Injections IP q.s. |
| Dosage Form | Powder for Injection |
| Concentration | 0.1 mg/ml |
| Container Type | Ampoule |
| Route of Administration | Intravenous |
| Mfg Lic No | K. M. 001/2019 |
| Marketed By | Eustoma Laboratories Pvt. Ltd. |
| Suitable For | pharmaceutical distributors and export houses |
| Target Buyers | institutional buyers such as hospitals, clinics, and healthcare networks |
| Target Condition | hepatorenal syndrome |
| Composition per ML | Terlipressin BP 0.1 mg (As Terlipressin Acetate) |
| Company Certification | AN ISO 9001:2015 Certified Company |
| Manufacturing Location | Bhopal, Madhya Pradesh |
| Minimum Order Quantity Applies | Yes |
Trade and Delivery
| Seller Location | Bhopal, Madhya Pradesh |
|---|---|
| Ships To | Pan India and international markets |
| HSN / SAC Code | 3004 |
Description
Terlipressin 0.1 mg/ml injection, supplied in ampoules for intravenous administration, is produced for institutional buyers such as hospitals, clinics, and healthcare networks, targeting hepatorenal syndrome treatment.
Key Features
- API Name: Terlipressin – a critical active pharmaceutical ingredient for specific medical treatments.
- Concentration: 0.1 mg/ml – precisely formulated for accurate dosage and therapeutic efficacy.
- Dosage Form: Injection – designed for rapid and effective systemic delivery.
- Composition per ml: Terlipressin BP 0.1 mg (As Terlipressin Acetate) – ensures adherence to pharmacopoeial standards.
- Excipients: Water for Injections IP q.s. – formulated with high-purity water for safe parenteral use.
- Route of Administration: Intravenous – suitable for direct administration into the bloodstream for immediate action.
- Container Type: Ampoule – sterile, single-dose packaging for secure and contamination-free delivery.
- Target Condition: Hepatorenal syndrome – specifically indicated for managing this severe medical condition.
- Company Certification: AN ISO 9001:2015 Certified Company – demonstrates adherence to international quality management standards.
Applications
- Hospitals: For critical care units and nephrology departments treating hepatorenal syndrome.
- Clinics: Specialised clinics requiring specific pharmaceutical agents for patient care.
- Healthcare Networks: Centralised procurement for multiple facilities within a network.
- Export Houses: For international distribution to healthcare providers and markets.
- Emergency Medical Services: For rapid intervention in acute medical scenarios requiring Terlipressin.
Detailed Description
Terlipressin 0.1 mg/ml injection is a pharmaceutical product formulated for intravenous administration, supplied in ampoules. Each ml contains Terlipressin BP 0.1 mg (as Terlipressin Acetate) with Water for Injections IP q.s. as excipients. This product is made in-house at our Bhopal, Madhya Pradesh facility, ensuring consistent quality and supply. It is specifically indicated for the treatment of hepatorenal syndrome, providing a critical therapeutic option for medical facilities managing this condition. Procurement managers can rely on this product for consistent supply in their inventory management. Our manufacturing processes adhere to stringent quality standards, as evidenced by our AN ISO 9001:2015 certification. The product is marketed by Eustoma Laboratories Pvt. Ltd. under manufacturing license number K. M. 001/2019, ensuring compliance with regulatory requirements for pharmaceutical products.
Sold By
Eustoma Laboratories Pvt. Ltd.
Verified Seller · Bhopal, Madhya Pradesh
Bhopal-based Manufacturer & Trader, 13 yrs. in Healthcare, Beauty, Food & Agriculture. Pan-India & Intl. Inc., IEC, FSSAI certified.
Checked by Tradoi
- GST Registration
- FSSAI License
- IEC
- Certificate of Incorporation
Said by the Seller
- Export Ready
- Online presence
- Manufacturer, Trader
- In business since 2013
- 50 staff
- Monthly capacity 10,00,000 pieces
- Reach: Pan India, International
Seen on Tradoi
- On Tradoi since May 2026
329 Items in Catalog
More from Eustoma Laboratories Pvt. Ltd.
Other Products from This Seller's Catalog
Similar Products from Other Sellers
Common Buyer Questions
Based on the seller's listing. Don't see your question? Ask the seller in chat.
What is the minimum order quantity for Terlipressin 0.1 mg/ml Injection Ampoule?
The minimum order quantity (MOQ) for Terlipressin 0.1 mg/ml Injection Ampoule is 10 units.
Who supplies Terlipressin 0.1 mg/ml Injection Ampoule?
Terlipressin 0.1 mg/ml Injection Ampoule is supplied by Eustoma Laboratories Pvt. Ltd., a Tradoi-verified manufacturer based in Bhopal, Madhya Pradesh.
What is the price of Terlipressin 0.1 mg/ml Injection Ampoule?
Terlipressin 0.1 mg/ml Injection Ampoule is priced at ₹300 per unit by Eustoma Laboratories Pvt. Ltd. Minimum order quantity is 10 units. Pricing may vary with order volume — contact the supplier on Tradoi to confirm bulk rates.
How can I buy Terlipressin 0.1 mg/ml Injection Ampoule in bulk?
Terlipressin 0.1 mg/ml Injection Ampoule is available for bulk purchase directly from Eustoma Laboratories Pvt. Ltd. in Bhopal on Tradoi. Submit an RFQ or contact the supplier to discuss volumes above 10 units and negotiate pricing.